AAP
CDLX icon

Arax Advisory Partners’s Cardlytics CDLX Stock Holding History

Arax Advisory Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Buy
+2
New +$15 ﹤0.01% 5189
2024
Q3 		– Sell
-46
Closed -$3.79K – 2630
2024
Q2 		$3.79K Buy
+46
New +$4.97K ﹤0.01% 1710

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arax Advisory Partners's CDLX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Cardlytics (CDLX) in Q2 2026: 2 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #5189 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in CDLX as recently as Q2 2024.

Arax Advisory Partners first reported a position in CDLX in Q2 2024 and has held it in 2 quarters since. The position peaked at $3.79K in Q2 2024. 43 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Arax Advisory Partners held 2 shares of Cardlytics worth $9 as of Q2 2026.
  • Cardlytics was a new Arax Advisory Partners position in Q2 2026.
  • Cardlytics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5189 holding.
  • Arax Advisory Partners first reported a position in Cardlytics in Q2 2024 and has held it in 2 quarters since.
  • Arax Advisory Partners's Cardlytics position peaked at $3.79K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.